SPOP mutation as a predictive marker for treatment of metastatic castration-resistant prostate cancer.

160Background: Predictive markers linking molecular background to treatment response and clinical outcomes are currently lacking in prostate cancer. Missense mutations in SPOP (speckle-type POZ pro...